May is World Trade Month—a celebration of the industries that import and export goods and services around the world. The month offers a good opportunity to examine the significance of international trade agreements and highlight the important economic role that the innovative biopharmaceutical sector plays both domestically and abroad. As it continues to build on the pro-innovation provisions of the United States-Mexico-Canada Agreement (USMCA), the United States has several major opportunities to raise global standards even further. The successful pursuit of an ambitious trade agenda will help to deliver lifesaving medicines to patients both today and in the future. Read more here.